ABL1 and acute leukemia: Until the diagnosis is confirmed by the detection of BCR::ABL1 and the definition of the immunophenotype (lymphoid vs. myeloid), supportive therapy is administered as in acute leukemia (prevention of tumor lysis syndrome according to institutional standards).